↓ Skip to main content

A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival

Overview of attention for article published in Frontiers in endocrinology, August 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival
Published in
Frontiers in endocrinology, August 2022
DOI 10.3389/fendo.2022.941210
Pubmed ID
Authors

Wu-Hu Zhang, He-Li Gao, Wen-Sheng Liu, Yi Qin, Zeng Ye, Xin Lou, Fei Wang, Yue Zhang, Xue-Min Chen, Jie Chen, Xian-Jun Yu, Qi-Feng Zhuo, Xiao-Wu Xu, Shun-Rong Ji

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 17%
Researcher 1 17%
Student > Doctoral Student 1 17%
Student > Master 1 17%
Unknown 2 33%
Readers by discipline Count As %
Nursing and Health Professions 2 33%
Medicine and Dentistry 2 33%
Unknown 2 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2022.
All research outputs
#21,649,033
of 26,580,681 outputs
Outputs from Frontiers in endocrinology
#7,356
of 13,624 outputs
Outputs of similar age
#325,990
of 439,249 outputs
Outputs of similar age from Frontiers in endocrinology
#491
of 1,021 outputs
Altmetric has tracked 26,580,681 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,624 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,249 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,021 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.